The tumor microenvironment as a metabolic barrier to effector T cells and immunotherapy

por Lim, Aaron R, Rathmell, W Kimryn, Rathmell, Jeffrey C
Publicado 2020

SETD2 loss sensitizes cells to PI3Kβ and AKT inhibition

por Terzo, Esteban A., Lim, Aaron R., Chytil, Anna, Chiang, Yun Chen, Farmer, Leah, Gessner, Kathryn H., Walker, Cheryl Lyn, Jansen, Valerie M., Rathmell, W. Kimryn
Publicado 2019

Correction: SETD2 loss sensitizes cells to PI3Kβ and AKT inhibition

por Terzo, Esteban A., Lim, Aaron R., Chytil, Anna, Chiang, Yun Chen, Farmer, Leah, Gessner, Kathryn H., Walker, Cheryl Lyn, Jansen, Valerie M., Rathmell, W. Kimryn
Publicado 2019

Clinical Features and Multiplatform Molecular Analysis Assist in Understanding Patient Response to Anti-PD-1/PD-L1 in Renal Cell Carcinoma

por Shiuan, Eileen, Reddy, Anupama, Dudzinski, Stephanie O., Lim, Aaron R., Sugiura, Ayaka, Hongo, Rachel, Young, Kirsten, Liu, Xian-De, Smith, Christof C., O’Neal, Jamye, Dahlman, Kimberly B., McAlister, Renee, Chen, Beiru, Ruma, Kristen, Roscoe, Nathan, Bender, Jehovana, Ward, Joolz, Kim, Ju Young, Vaupel, Christine, Bordeaux, Jennifer, Ganesan, Shridar, Mayer, Tina M., Riedlinger, Gregory M., Vincent, Benjamin G., Davis, Nancy B., Haake, Scott M., Rathmell, Jeffrey C., Jonasch, Eric, Rini, Brian I., Rathmell, W. Kimryn, Beckermann, Kathryn E.
Publicado 2021